abstract |
The present invention relates to 5H-benzo[4,5]cyclohepta[1,2] for use in the treatment of cell proliferative diseases, for the treatment of conditions associated with MET activity, and for the inhibition of the receptor tyrosine kinase MET -b] pyridine compounds. The invention also relates to compositions comprising these compounds, and methods of using these compounds to treat cancer in mammals. |